Transcription of The PATH study - CIDP Treatment With …
{{id}} {{{paragraph}}}
Example: biology
The PATH study - CIDP Treatment With …
1 Hizentra CIDP (PATH) IgPro20_3003 K. Goodwin 21 Nov. 2012 The PATH study - CIDP Treatment with subcutaneous immunoglobulin ( igpro20 ) CSL Behring is currently recruiting patients for the PATH study , an international clinical trial designed to evaluate the effectiveness of igpro20 compared with placebo in the Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). The study will also look at the safety and tolerability of these doses. Intravenous immunoglobulins (IVIG), steroids and plasma exchange are recommended Treatment options for CIDP, although only one IVIG has received official marketing approval.
1 Hizentra CIDP (PATH) – IgPro20_3003 K. Goodwin 21 Nov. 2012 The PATH study - CIDP Treatment With Subcutaneous Immunoglobulin (IgPro20) CSL Behring is currently recruiting patients for the PATH study, an international clinical
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Intravenous Immunoglobulin, Human normal immunoglobulin for i.m, Human normal immunoglobulin for, Immune Globulin Intravenous Human, Intravenous, Tetanus Immunoglobulin-VF For Intramuscular, Immunoglobulin, Tetanus Immunoglobulin-VF For Intramuscular Use, Prescribe differs for each, Prescribe differs for each individual based